TY - JOUR
KW - Dapsone
KW - Immunosuppression
KW - leprosy
KW - Leprosy reactions
KW - PJP prophylaxis
AU - Ramírez-Perea N
AU - Moran-Castaño C
AU - Perez-Molina J
AB - <p>Leprosy reactions often require prolonged high-dose steroids or immunosuppressive drugs, putting patients at risk of Pneumocystis jirovecii pneumonia (PJP). However, no PJP cases are reported, possibly due to dapsone treatment for leprosy. In patients with leprosy reactions not receiving dapsone because of toxicity or resistance and requiring long-term immunosuppression, PJP prophylaxis should be considered.</p>

BT - Pneumonia (Nathan Qld.)
C1 - <p>https://www.ncbi.nlm.nih.gov/pubmed/38576014</p>

DA - 04/2024
DO - 10.1186/s41479-024-00127-x
IS - 1
J2 - Pneumonia (Nathan)
LA - eng
N2 - <p>Leprosy reactions often require prolonged high-dose steroids or immunosuppressive drugs, putting patients at risk of Pneumocystis jirovecii pneumonia (PJP). However, no PJP cases are reported, possibly due to dapsone treatment for leprosy. In patients with leprosy reactions not receiving dapsone because of toxicity or resistance and requiring long-term immunosuppression, PJP prophylaxis should be considered.</p>

PY - 2024
SP - 1
EP - 3
T2 - Pneumonia (Nathan Qld.)
TI - Should prophylaxis against Pneumocystis jirovecii pneumonia be considered in selected patients with leprosy reactions?
UR - https://pneumonia.biomedcentral.com/counter/pdf/10.1186/s41479-024-00127-x.pdf
VL - 16
SN - 2200-6133
ER -